Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate.

MLA

van Kol, Kim, et al. “Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate.” Cancers, vol. 13, no. 24, Dec. 2021, p. 6190. EBSCOhost, https://doi.org/10.3390/cancers13246190.

APA

van Kol, K., Ebisch, R., Piek, J., Beugeling, M., Vergeldt, T., & Bekkers, R. (2021). Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate. Cancers, 13(24), 6190. https://doi.org/10.3390/cancers13246190

Chicago

van Kol, Kim, Renée Ebisch, Jurgen Piek, Maaike Beugeling, Tineke Vergeldt, and Ruud Bekkers. 2021. “Adjuvant Hysterectomy for Cervical Cancer Patients Treated with Chemoradiation Therapy: A Systematic Review on the Pathology-Proven Residual Disease Rate.” Cancers 13 (24): 6190. doi:10.3390/cancers13246190.